Amneal Pharmaceuticals (AMRX) Times Interest Earned (2017 - 2026)

Amneal Pharmaceuticals' Times Interest Earned history runs 10 years deep, the most recent figure standing at $1.2 for Q1 2026.

• On a quarterly basis, Times Interest Earned rose 10.86% year-over-year to $1.2 in Q1 2026; TTM through Mar 2026 was $3.7, a 5.18% decrease from a year earlier, with the FY2025 full-year figure at $0.67, up 59.07% from the prior year.
• Times Interest Earned declined to $1.2 in Q1 2026 per AMRX's latest filing, from $2.71 in the prior quarter.
• Across five years, Times Interest Earned topped out at $2.73 in Q4 2022 and bottomed at -$2.75 in Q2 2022.
• The 5-year median for Times Interest Earned is $0.25 (2023), against an average of $0.54.
• Across the five-year window, Times Interest Earned tumbled 816.23% in 2022 and surged 5820.76% in 2025, its largest moves.
• Year by year, Times Interest Earned stood at $2.73 in 2022, then sank by 90.76% to $0.25 in 2023, then slumped by 254.94% to -$0.39 in 2024, then jumped by 791.62% to $2.71 in 2025, then slumped by 55.5% to $1.2 in 2026.
• Per Business Quant, the three latest AMRX Times Interest Earned figures stand at $1.2 (Q1 2026), $2.71 (Q4 2025), and $0.56 (Q3 2025).